REQUEST A DEMO
Total
USD $0.00
Search more companies

Daewoong Co.,Ltd. (Seongnam) (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Management of Companies and Enterprises
Full name: Daewoong Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Daewoong pharmaceutical Co.,Ltd. specializes in the research, development, and manufacturing of pharmaceutical products, including new drugs, biologics, and stem cell therapy. It focuses on innovative treatments for chronic and orphan diseases, as well as autoimmune diseases. Daewoong Pharmaceutical has partnerships with healthcare companies worldwide and operates research and development centers in various countries. The company claims to have acquired various certifications, including ISO 9001 and ISO 45001.

Headquarters
223-23 Sangdaewon-Dong, Joongwon-Gu, Seongnam-Si
Seongnam; Gyeonggi; Postal Code: 462-120

Contact Details: Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.

Website: http://www.daewoong.com

Basic Information
Total Employees:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Outstanding Shares:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Registered Capital:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Financial Auditors:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Incorporation Date:
January 10, 1961
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
11.61%
Purchase this report to view the information.
10.51%
Purchase this report to view the information.
9.7%
Purchase this report to view the information.
9.21%
Purchase this report to view the information.
5.42%
Subsidiaries
(주)대웅개발
(주)대웅경영개발원
(주)대웅생명과학
Company Performance
Financial values in the chart are available after Daewoong Co.,Ltd. (Seongnam) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
1.31%
Total operating revenue
1.23%
Operating profit (EBIT)
-25.71%
EBITDA
-18.82%
Net Profit (Loss) for the Period
-55.78%
Total assets
13.95%
Total equity
7.5%
Operating Profit Margin (ROS)
-3.24%
Net Profit Margin
-6.11%
Return on Equity (ROE)
-4.22%
Debt to Equity Ratio
-0.29%
Quick Ratio
-0.31%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?